Warning: Creating default object from empty value in /homepages/24/d269161222/htdocs/2006/beta/wp-includes/functions.php on line 292
Eurogin 2006 : Human Papillomavirus Infection and Global Prevention of Cervical Cancer

6th Internation Multidisciplinary Congress


Strict Standards: mktime(): It is not safe to rely on the system's timezone settings. You are *required* to use the date.timezone setting or the date_default_timezone_set() function. In case you used any of those methods and you are still getting this warning, you most likely misspelled the timezone identifier. We selected 'Europe/Berlin' for 'CEST/2.0/DST' instead in /homepages/24/d269161222/htdocs/2006/beta/wp-includes/functions.php on line 24

Strict Standards: date(): It is not safe to rely on the system's timezone settings. You are *required* to use the date.timezone setting or the date_default_timezone_set() function. In case you used any of those methods and you are still getting this warning, you most likely misspelled the timezone identifier. We selected 'Europe/Berlin' for 'CEST/2.0/DST' instead in /homepages/24/d269161222/htdocs/2006/beta/wp-includes/functions.php on line 26

Strict Standards: date(): It is not safe to rely on the system's timezone settings. You are *required* to use the date.timezone setting or the date_default_timezone_set() function. In case you used any of those methods and you are still getting this warning, you most likely misspelled the timezone identifier. We selected 'Europe/Berlin' for 'CEST/2.0/DST' instead in /homepages/24/d269161222/htdocs/2006/beta/wp-includes/functions.php on line 28

Strict Standards: mktime(): It is not safe to rely on the system's timezone settings. You are *required* to use the date.timezone setting or the date_default_timezone_set() function. In case you used any of those methods and you are still getting this warning, you most likely misspelled the timezone identifier. We selected 'Europe/Berlin' for 'CEST/2.0/DST' instead in /homepages/24/d269161222/htdocs/2006/beta/wp-includes/functions.php on line 24

Strict Standards: date(): It is not safe to rely on the system's timezone settings. You are *required* to use the date.timezone setting or the date_default_timezone_set() function. In case you used any of those methods and you are still getting this warning, you most likely misspelled the timezone identifier. We selected 'Europe/Berlin' for 'CEST/2.0/DST' instead in /homepages/24/d269161222/htdocs/2006/beta/wp-includes/functions.php on line 26

Strict Standards: date(): It is not safe to rely on the system's timezone settings. You are *required* to use the date.timezone setting or the date_default_timezone_set() function. In case you used any of those methods and you are still getting this warning, you most likely misspelled the timezone identifier. We selected 'Europe/Berlin' for 'CEST/2.0/DST' instead in /homepages/24/d269161222/htdocs/2006/beta/wp-includes/functions.php on line 28

Deprecated: preg_replace(): The /e modifier is deprecated, use preg_replace_callback instead in /homepages/24/d269161222/htdocs/2006/beta/wp-includes/functions-formatting.php on line 76
human papillomavirus

POSTERS

Anal Neoplasia

PO-01 MARTINS / ORNELAS L. PORTUGAL PREVALENCE OF HUMAN PAPILLOMAVIRUS DNA IN ANAL WARTS AND CARCINOMAS

Biomarkers

PO2-01 FITZKY B. AUSTRIA HPV E7 ONCOPROTEINS AS POTENTIAL MOLECULAR MARKER FOR CERVICAL CANCER SCREENING
PO2-02 KRIVAK BOLANCA I. Croatia OVEREXPRESSION OF PROTEIN p16 INK4a AS A MARKER FOR CERVICAL DYSPLASIA INDUCED BY HPV INFECTION

Cervical Cancer

PO3-02A MOODLEY M. SOUTH AFRICA “REDUCTION” IN PREVALENCE OF INVASIVE CERVICAL CANCER IN KWAZULU NATAL, SOUTH AFRICA: IMPACT OF THE HUMAN IMMUNODEFICIENCY VIRUS (HIV) EPIDEMIC
PO3-03 PRZYBYLSKI M. POLAND MARKERS OF EARLY CIN PROGRESSION

Cervical Neoplasia

PO4-01 DIVANI/MARGARI S. GREECE ATYPICAL ENDOCERVICAL CELLS.WHAT IS THEIR SIGNIFICANCE?
PO4-02 DÖRR A. CZECH REPUBLIC SENTINEL NODE DETECTION IN EARLY STAGE OF CERVICAL NEOPLASIA
PO4-03 ENERSON C. USA Feasibility of cryotherapy without biopsy confirmation of CIN 2 or 3 in women with two positive self-tests for high-risk human papillomavirus (HPV) and two negative acetic acid aided visual inspections (VIA) 12 months apart
PO4-04A FURTADO DE MELO Y.L. BRAZIL Low Grade Intraepithelial Lesion: The Colposcopic Following Importance
PO4-05A KYRGIOU M UK OBSTETRIC AND FERTILITY OUTCOMES AFTER CONSERVATIVE TREATMENT FOR INTRA-EPITHELIAL OR EARLY INVASIVE CERVICAL LESIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF THE LITERATURE
PO4-06 LAI H.C. Taiwan THE EXPRESSION OF DNA METHYLTRANSFEARSES IN CERVICAL NEOPLASMS AND IMPLICATIONS IN CANCER INVASION
PO4-07A MADHURI T. UK CARCINOMA OR METAPLASIA: A HISTOLOGICAL DILEMMA
PO4-09 OSTERGARD M. DENMARK LONG-TERM FOLLOW-UP ON CERVICAL SMEAR TEST IN WOMEN WITH A NEGATIVE SCREENING HISTORY
PO4-11 SILVEIRA F. BRAZIL Low Grade Intraepithelial Lesion: the Colposcopic Following Importance
PO4-12A VLASTOS A.T. SWITZERLAND CERVICAL METASTASIS OF BREAST CANCER

Colposcopy

PO5-02 BEHTASH N, IRAN Cervical pathology in women presenting with postcoïtal bleeding
PO4-04B FURTADO DE MELO Y.L. BRAZIL Margins Status after LLETZ: are there risk factors?
PO5-06A NAUD P. BRAZIL POSITIVE PREDICTIVE VALUE OF COLPOSCOPIC FINDINGS FOLLOWING THE INTERNATIONAL FEDERATION FOR CERVICAL PATHOLOGY AND COLPOSCOPY (IFCPC) 2002 TERMINOLOGY
PO5-07 PERRINI G. ITALY IS COLPOSCOPIC GRADING A PREDICTIVE FACTOR FOR HYSTOLOGICAL GRADE OF CERVICAL INTRAEPITHELIAL LESION OF LEEP SPECIMENS?
PO5-08 RAY P. UK PRIMARY CARE SECTOR VERSUS HOSPITAL FOLLOW-UP FOR TREATED CIN: WHICH IS THE "BEST PRACTICE" ?
PO5-01 ARAFA A. UK CASE CONTROL STUDY OF PREGNANCY OUTCOME AND MORBIDITY, FOLLOWING SINGLE LASER/LLETZ PROCEDURE FOR CIN PATIENTS
PO7-01 BREUGELMANS G. FRANCE INVASIVE CERVICAL CANCER TREATMENT COSTS IN FRANCE
PO7-02 MARTIN HIRSH P. UK EVALUATING MANAGEMENT PATTERNS AND ASSOCIATED COSTS OF ABNORMAL CERVICAL CYTOLOGY IN ENGLAND AND WALES

Epidemiology

PO8-01 JERBI E. TUNISIA HUMAN PAPILLOMAVIRUS DETECTION AND TYPING IN A TUNISIAN POPULATION USING POLYMERASE CHAIN REACTION
PO8-02A KIM C.J. KOREA The Clearance of Human Papillomavirus in Korean women without cervical conization
PO8-03 PISTA A. PORTUGAL ASSOCIATION BETWEEN p53 POLYMORPHISM AND THE RISK OF CERVICAL NEOPLASIA IN A GROUP OF PORTUGUESE WOMEN
PO8-04 RAMA C. BRAZIL Prevalence, Age Distribution and Risk Factors of High Risk Human Papillomavirus Infection Among Women in Brazil

Epidemiology and Natural History

PO5-06B NAUD P. BRAZIL THE INCIDENCE OF GENITAL HPV INFECTIONS IN SOUTH OF BRAZIL
PO5-06C NAUD P. BRAZIL SPONTANEOUS REGRESSION OF ASYMPTOMATIC HPV INFECTIONS IN SOUTH OF BRAZIL
PO9-03A VINOKUROVA S. GERMANY CLONAL HISTORY OF PAPILLOMAVIRUS-INDUCED DYSPLASIA IN THE FEMALE LOWER GENITAL TRACT

Genital Warts

PO10-01 BOUCHARD C. CANADA PREFERENCE FOR THE TREATMENT OF GENITAL WARTS: SURVEY OF 361 FRENCH CANADIAN WOMEN
PO10-02 BOUDGHENE STAMBOULI O. ALGERIE SEXUALLY TRANSMITTED DISEASES AND GENITAL WARTS. EXPERIENCE IN THE DEPARTMENT OF DERMATO-VENEREOLOGY OF TLEMCEN (Algeria)
PO10-03 FORTIER M. CANADA MOTIVES FOR CHOOSING IMIQUIMOD OR DESTRUCTIVE THERAPY FOR GENITAL WARTS: SURVEY OF 361 FRENCH CANADIAN WOMEN

Genotyping

PO11-01 BULKMANS N. NETHERLANDS HPV TYPE-SPECIFIC 18-MONTH RISK OF HIGH-GRADE CERVICAL INTRAEPITHELIAL NEOPLASIA IN WOMEN WITH A NORMAL OR BORDERLINE/MILDLY DYSKARYOTIC SMEAR
PO11-02A CRICCA M. ITALY ANALYSIS OF E6* SPLICED PRODUCTS OF HPV 16 AS MOLECULAR MARKERS OF CERVICAL DISEASE PROGRESSION.
PO11-03 FREITAG P. CZECH REPUBLIC HPV AND HLA GENOTYPING IN CERVICAL INTRAEPITHELIAL NEOPLASIA
PO11-04 RODRIGUES-IGLESIAS M. SPAIN COMPARISON OF THREE HYBRIDIZATION METHODS FOR THE HUMAN PAPILLOMAVIRUS GENOTYPING

HPV testing

PO12-01 BAENA J. COLOMBIA DETECTION OF THE ONCOGENIC HUMAN PAPILLOMAVIRUS IN WOMEN WITH A CYTOLOGICAL DIAGNOSIS OF ASCUS, USING IMMUNOHISTOCHEMESTRY IN THE "LABORATORIO CENTRAL DE CITOPATOLOGIA" IN THE JULY TO DECEMBER OF 2003 PERIOD
PO12-02 CAROZZI F. ITALY Analysis of Human Papillomavirus type 16 E6 variants in relation to P53 codon 72 polymorphism genotype in a group of Italian women
PO12-03 CHARKVIANI / DVALISHVILI T. GEORGIA Detection of human papillomavirus in endocervical glandular lesions and relationship with p53 and MIB-1 expressions
PO12-04 CLAEYS P. BELGIUM Prevalence of high-risk human papillomavirus types among Nicaraguan women with histological proven pre-neoplastic and neoplastic lesions of the cervix.
PO12-05 COMAN N. ROMANIA INCIDENCE OF HPV INFECTION IN ROAMANIA BY SFP(10)LIPA METHOD
PO11-02B CRICCA M, ITALY APPLICATION OF THE NASBA METHOD FOR THE DETECTION OF THE HUMAN PAPILLOMAVIRUS E6-E7 TRANSCRIPTS IN PATIENTS TREATED FOR HIGH GRADE CIN AND POSITIVE TO HPV 16
PO12-07 DERCHAIN S. BRAZIL GLANDULAR CELL ABNORMALITIES IN CONVENTIONAL CERVICAL SMEARS: CYTOMORPHOLOGIC CRITERIA AND HPV TEST
PO12-08 DÜRST M. GERMANY RE-TESTING OF CERVICAL SCRAPES TAKEN AT BASELINE OF WOMEN WHO HAD PREVALENT OR INCIDENT CIN2, CIN3 OR CANCER (CIN2+) WITHIN 5 YEARS USING THE AMPLICOR HPV TEST
PO12-09 GIRALDO P. BRAZIL PROGNOSTIC MARKERS OF HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESIONS: THE ROLE OF p16INK4a AND HIGH RISK HPV
PO12-10 HUANG S.L. TAIWAN Comparison between the Hybrid Capture II test and a SPF1/GP6+ PCR-based assay for detection of human papillomavirus DNA in cervical swab samples
PO12-13 KOLK D. USA CHARACTERIZATION OF A PROTOTYPE TRANSCRIPTION-MEDIATED AMPLIFICATION BASED DIAGNOSTIC ASSAY FOR DETECTION OF HPV E6/E7 MRNA IN LBC MEDIA
PO12-14A KUEVDA D. Russia NOVEL HIGH-RISK HPV DNA DETECTION KIT FOR LOW-INCOME COUNTRIES
PO12-15 MIZUNUMA M. JAPAN HUMAN PAPPILOMAVIRUS (HPV) GENOTYPE DETECTED BY LINEAR ARRAY ASSAY IN CERVICAL SAMPLES OF JAPANESE WOMEN.
PO12-16 MOCIULSCHI R. ROMANIA CORRELATION BETWEEN CYTOLOGICAL ABNORMALITIES AND HPV GENOTYPES DETECTION IN THE CERVICAL LESIONS
PO03-02B MOODLEY M. SOUTH AFRICA THE SIGNIFICANCE OF HUMAN PAPILLOMAVIRUS INFECTION (HPV) DETECTED BY CERVICAL CYTOLOGY AMONG WOMEN INFECTED WITH THE HUMAN IMMUNODEFICIENCY VIRUS (HIV)
PO12-18 MUSANTE S. USA A HIGHLY SENSITIVE IN SITU HYBRIDIZATION ASSAY FOR DETECTION OF HPV IN LIQUID BASED CYTOLOGY AND CERVICAL TISSUE SAMPLES
PO12-20 PRANDI S. ITALY APPLICATION HPV TEST (HC2) IN MANAGEMENT OF COLPOSCOPY IN THE SCREENING PROGRAMME OF REGGIO EMILIA, ITALY
PO12-21 REBELLO G. UK HOW LONG DOES HPV PERSIST?
PO12-22 SALFA M.C. ITALY PREVALENCE AND DETERMINANTS OF HPV INFECTION AMONG ITALIAN WOMAN
PO12-23 SCHALASTA G. GERMANY AMPLICOR Human Papilloma Virus (HPV) Test. A comparative analysis of two different nucleic acid extraction techniques.
PO12-24 SHIPITSYNA E. RUSSIA TYPE-SPECIFIC PERSISTENCE OF HIGH-RISK HUMAN PAPILLOMAVIRUS DNA

Liquid Based Cytology

PO14-01 ANDERSSON S. SWEDEN A comparison of the liquid-based cytology and Pap smear as a second screening method for women with cytological abnormalities
PO14-02 GIORGADZE T. USA NUCLEAR GROOVES ARE SIGNIFICANTLY INCREASED IN BENIGN INTERMEDIATE CELLS OF HSIL CASES IN THINPREP SPECIMENS
PO14-03 MARGARI H. GREECE SIGNIFICANCE OF KERATINIZATION WITH ATYPIA ON ASCUS OR OTHERWISE NORMAL PAP SMEARS AS A PREDICTOR OF HUMAN PAPILLOMA VIRUS INFECTION
PO14-05 NICOLL S. UK IMPLEMENTATION OF THINPREP LBC IN A REGIONAL SCOTTISH LABORATORY:IMPACT ON QUALITY PARAMETERS AND LABORATORY WORKLOAD

Management

PO15-01A GUEDES /BRENNA A.C. BRAZIL Cost-benefits of cold-knife conization and large-loop excision at public health service in Brazil
PO15-01B GUEDES /BRENNA A.C. BRAZIL No treatment versus large-loop excision for CIN2 and association between p16 and its evolution

Management of CIN

PO16-01 LONKY N. USA Demonstration of a Novel Hemostatic Topical Agent to Control Bleeding During and Following Colposcopic Biopsy and the Loop Electrosurgical Excision Procedure (LEEP).

Molecular Biology Carcinogenesis

PO17-01 BIESAGA B. POLAND PROGNOSTIC SIGNIFICANCE OF HUMAN PAPILOMA VIRUS TYPE 16 AND 18 (HPV16/18) INFECTION IN RADIOTHERAPY OF CERVICAL CANCER

Molecular Markers

PO18-01 KUEVDA D. RUSSIA HIGH VIRAL LOAD AND INTEGRATION OF HPV16 AS MARKERS OF H-SIL AND CERVICAL CARCINOMA
PO18-02 SOKOLOVA I. RUSSIA Chromosome Markers for detection of HPV-associated genome instability in cervical lesions

New Technologies

PO04-05B KYRGIOU M. UK A SUSCEPTIBILITY-TO-CARCINOMA SPECTRAL SIGNATURE IN LIQUID BASED CYTOLOGY (LBC) USING ATTENUATED TOTAL REFLECTION FOURIER TRANSFORM INFRARED (ATR-FTIR) MICROSPECTROSCOPY: IDENTIFYING A BIOMARKER OF PROGRESSION

Protein Vaccine

PO20-01 CHENG W.F TAIWAN Fusion Protein Vaccine by Domains of Bacterial Exotoxin Linked with a Tumor Antigen Generates Potent Immunological Responses and Antitumor Effects

Screening Methods

PO21-01 BOMFIM-HYPPOLITO S BRAZIL CERVICOGRAPHY AS AN ADJUNCTIVE TEST TO VISUAL INSPECTION WITH ACETIC ACID IN CERVICAL CANCER DETECTION SCREENING
PO21-02 COLLACO L.M. BRAZIL THE EXPERIENCE OF CERVICAL CANCER SCREENING IN PROGRAM OF PARANÁ-BRAZIL
PO21-03 FABRI V. BELGIUM CERVICAL CANCER SCREENING COVERAGE IN BELGIUM
PO21-12 GRANGE G. FRANCE French women’s knowledge, attitudes and perceptions regarding HPV infections and cervical cancer screening
PO05-06D NAUD P. BRAZIL PATIENT COMPLIANCE TO CERVICAL CANCER SCREENING PROGRAM IN SOUTH OF BRAZIL
PO21-06 RAMACHANDRAN S. USA ALTERNATIVE TECHNOLOGIES FOR COST-EFFECTIVE HPV SCREENING IN DEVELOPING COUNTRIES
PO21-07 REBOLJ M. NETHERLANDS SUCCESSFUL CHANGES IN CERVICAL CANCER SCREENING IN THE NETHERLANDS
PO21-08 SCHLEDERMANN D, DENMARK Manual versus semi-automated screening
PO21-09 SUTEU O. ROMANIA STRATEGIES OF CERVICAL CANCER PREVENTION IN CLUJ COUNTY, ROMANIA
PO21-10 VRDOLJAK-MOZERIC D, CROATIA SCREENING PAP TEST, DIAGNOSTIC PAP TEST AND HPV TEST COMPARED TO THE HISTOLOGICAL DIAGNOSIS OF CIN2+ LESIONS

Sexually Transmitted Infections

PO22-01 MAHMUDOV F. AZERBAIDJAN The Evaluation of frequency of herpetic urethritis in male patients with genital herpes

Vaginal Neoplasia

PO4-12B VLASTOS A.T. SWITZERLAND PRIMARY MALIGNANT MELANOMA OF THE VAGINA (PMMV)

Viral and Molecular Biology

PO24-01 ANTON A.C. ROMANIA E-CADHERIN – MOLECULAR MARKER IN HPV CERVICAL PATHOLOGY
PO24-02 JOZEFIAK A. POLAND AN POLYMORPHISM IN POSTION -383 C→T IN IGF-1 P1 PROMOTER REGION DETECTED IN WOMEN HPV HIGH RISK POSITIVE
PO24-06 NAGORE N. MEXICO P53 AND BCL-2 PHENOTYPIC EXPRESSION, IN PRENOPLASIC AND NEOPLASIC LESIONS OF THE CERVIX
PO24-07 RESSLER S. AUSTRIA Expression of high-risk HPV E7 oncoproteins in cervical cancers
PO24-08 TUNGSINMUNKONG K. THAILAND HIGH-RISK HUMAN PAPILLOMAVIRUS AND p16INK4a PROTEIN EXPRESSION IN PRE-NEOPLASTIC AND INVASIVE CANCER OF THE CERVIX UTERI
PO24-09 VERANES E. CUBA COMPUTER-ANALYSIS OF TRANSCRIPTION FACTOR BINDING SITES IN LCR OF HPV 6, 11, 16, 18, 31, 39, 45, 52USING PROGRAMS BASED ON TRANSFAC® DATABASE.
PO9-03B VINOKUROVA S. GERMANY INTEGRATION FREQUENCY OF VIRAL GENOMES DIFFERS AMONG CERVICAL CANCERS INFECTED BY DIFFERENT HIGH RISK HPV TYPES

Vulvar Diseases

PO25-01 GONTIJO R. BRAZIL Human Papillomavirus (HPV) Infections as Risk Factors for Cytological and Histological Abnormalities in Baseline PAP Smear-Negative Women Followed-up for Two Years in the LAMS Study.
PO25-02 HAMPL M. GERMANY COMPREHENSIVE ANALYSIS OF DIFFERENT HPV TYPES IN VIN AND VULVAR CARCINOMA
PO25-03 LOPES PEREIRA M.L. PORTUGAL VULVAR DISEASE IN A CERVICAL DISEASE OUTPATIENT CONSULTATION: A THREE YEAR REVIEW
PO4-07B MADHURI T. UK VULVAL LEIOMYOSARCOMA: A RARE VARIANT
PO25-07 TACHEZY R. CZECH REPUBLIC THE RELATIONSHIP OF HPV TO THE PRE-MALIGNANT LESIONS AND CARCINOMA OF THE VULVA
PO4-12C VLASTOS A.T, SWITZERLAND OPTICAL BIOPSY OF VULVAR LESIONS
PO4-12D VLASTOS / BEFFA A.T. SWITZERLAND DIFFERENTIAL EXPRESSION OF MATRIX METALLOPROTEINASES 9 (MMP-9) AND CYCLINE B1 IN VULVAR INTRAEPITHELIAL NEOPLASIA (VIN) AND CARCINOMA.




Web analysis